Home/Filings/4/0000899243-16-034871
4//SEC Filing

APPLIED GENETIC TECHNOLOGIES CORP 4

Accession 0000899243-16-034871

CIK 0001273636operating

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 6:38 PM ET

Size

5.7 KB

Accession

0000899243-16-034871

Insider Transaction Report

Form 4
Period: 2016-12-01
Goldstein Michael H.
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2016-12-01+180,000180,000 total
    Exercise: $8.70Exp: 2026-12-01Common Stock (180,000 underlying)
Footnotes (1)
  • [F1]Option becomes exercisable for 25% of the underlying shares on the first anniversary of the grant date, and thereafter becomes exercisable for the remaining underlying shares in equal monthly installments over three years, resulting in the option being exercisable for 100% of the underlying shares on the fourth anniversary of the grant date.

Issuer

APPLIED GENETIC TECHNOLOGIES CORP

CIK 0001273636

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001273636

Filing Metadata

Form type
4
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 6:38 PM ET
Size
5.7 KB